RARE Corazon (Corsee) Sanders D. sells $90K worth of shares
Jun 24, 2025, 4:34 AM
0.00%
What does RARE do
Ultragenyx Pharmaceutical, based in Novato, California, focuses on developing therapies for rare genetic diseases and has four approved products, including Crysvita and Mepsevii. The company went public on January 31, 2014, and employs 1,276 people.
Corazon (Corsee) Sanders D. sold 2,405 shares of RARE on 20 June at $37.39 per share, worth a total of $90K. They now own 15,344 RARE shares, or a 14% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
